Adhera Therapeutics Insiders
ATRXDelisted Stock | USD 0.72 0.00 0.00% |
Adhera Therapeutics employs about 12 people. The company is managed by 2 executives with a total tenure of roughly 28 years, averaging almost 14.0 years of service per executive, having 6.0 employees per reported executive. Break down of Adhera Therapeutics' management performance can provide insight into the company performance.
Andrew MBA Chairman COO, Chairman |
Adhera |
Adhera Therapeutics Management Team Effectiveness
The company has return on total asset (ROA) of (4.484) % which means that it has lost $4.484 on every $100 spent on assets. This is way below average. Adhera Therapeutics' management efficiency ratios could be used to measure how well Adhera Therapeutics manages its routine affairs as well as how well it operates its assets and liabilities.Adhera Therapeutics Workforce Comparison
Adhera Therapeutics is rated third in number of employees category among its peers. The total workforce of Health Care industry is presently estimated at about 365. Adhera Therapeutics holds roughly 12.0 in number of employees claiming about 3% of equities under Health Care industry.
Adhera Therapeutics Notable Stakeholders
An Adhera Therapeutics stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Adhera Therapeutics often face trade-offs trying to please all of them. Adhera Therapeutics' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Adhera Therapeutics' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Andrew MBA | COO, Chairman | Profile | |
BS BS | Chief CEO | Profile |
About Adhera Therapeutics Management Performance
The success or failure of an entity such as Adhera Therapeutics often depends on how effective the management is. Adhera Therapeutics management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Adhera management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Adhera management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Adhera Therapeutics, Inc. focuses on the discovery and development of drugs. Adhera Therapeutics, Inc. is based in Baton Rouge, Louisiana. Adhera Therapeutics is traded on OTC Exchange in the United States.
Please note, the imprecision that can be found in Adhera Therapeutics' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Adhera Therapeutics. Check Adhera Therapeutics' Beneish M Score to see the likelihood of Adhera Therapeutics' management manipulating its earnings.
Adhera Therapeutics Workforce Analysis
Traditionally, organizations such as Adhera Therapeutics use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Adhera Therapeutics within its industry.Adhera Therapeutics Manpower Efficiency
Return on Adhera Therapeutics Manpower
Revenue Per Employee | 0.0 | |
Revenue Per Executive | 0.0 | |
Net Loss Per Employee | 529.2K | |
Net Loss Per Executive | 3.2M | |
Working Capital Per Employee | 1.4M | |
Working Capital Per Executive | 8.2M |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Other Consideration for investing in Adhera Pink Sheet
If you are still planning to invest in Adhera Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Adhera Therapeutics' history and understand the potential risks before investing.
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Stocks Directory Find actively traded stocks across global markets | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |